ClinVar Miner

Submissions for variant NM_000744.7(CHRNA4):c.1525G>A (p.Ala509Thr)

gnomAD frequency: 0.00005  dbSNP: rs142137599
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000116719 SCV000150690 uncertain significance not provided 2013-10-14 criteria provided, single submitter clinical testing
GeneDx RCV000116719 SCV000240523 uncertain significance not provided 2018-02-05 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the CHRNA4 gene. The A509T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The A509T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The A509T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this amino acid substitution is not predicted to occur within the transmembrane region of the protein, where the vast majority of pathogenic missense variants have been identified in association with epilepsy (Steinlein et al., 2010). In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Ambry Genetics RCV000624743 SCV000742167 uncertain significance Inborn genetic diseases 2017-06-13 criteria provided, single submitter clinical testing
Ambry Genetics RCV000624743 SCV000848931 uncertain significance Inborn genetic diseases 2017-02-28 criteria provided, single submitter clinical testing The p.A509T variant (also known as c.1525G>A), located in coding exon 5 of the CHRNA4 gene, results from a G to A substitution at nucleotide position 1525. The alanine at codon 509 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV002512515 SCV003285204 likely benign Autosomal dominant nocturnal frontal lobe epilepsy 2023-11-12 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.